Besides the injection of exogenous BDNF, there are relevant data that Galectin-1 (Gal-1), a soluble carbohydrate-binding protein that is widely expressed in both neurons and glia, can enhance astrocytic BDNF production and improve functional outcomes in rats following brain ischemia. Here, LGALS1 is linked to brain ischemia.